Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer

Clinical trial NCT06454383 · RECRUITING

Trial details

NCT number: NCT06454383
Sponsor: City of Hope Medical Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Pancreatic Adenocarcinoma Stage III Pancreatic Cancer AJCC v8 Stage IV Pancreatic Cancer AJCC v8 Unresectable Pancreatic Ductal Adenocarcinoma

Start date: 2024-05-13
Primary completion: 2026-11-13
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.